BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28665687)

  • 1. Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.
    Zhao Z; Zhang G; Li W
    DNA Cell Biol; 2017 Sep; 36(9):781-786. PubMed ID: 28665687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
    Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
    Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M
    Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
    Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
    Lee JH; Lee SW
    Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
    Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Li J; Li X; Cen C; Ai X; Lin C; Hu G
    Oncol Rep; 2018 Jan; 39(1):217-226. PubMed ID: 29115526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
    Hu H; Wang M; Guan X; Yuan Z; Liu Z; Zou C; Wang G; Gao X; Wang X
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29371412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
    Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
    Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
    Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
    Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.
    Blondy S; Talbot H; Saada S; Christou N; Battu S; Pannequin J; Jauberteau MO; Lalloué F; Verdier M; Mathonnet M; Perraud A
    J Cell Mol Med; 2021 Jan; 25(1):47-60. PubMed ID: 33325631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.